drugset / Trial / NCT03309163

Effect of Tramadol in Prevention of Postpartum Depression

NCT03309163

Phase 4 Completed 1230 enrolled Xinqiao Hospital of Chongqing
RandomizedParallel-groupTriple-blindPrevention

Summary

The incidence of postpartum depression in Europe and the United States is about 10%, while in China the incidence rate of 15.7-39.8%. Postpartum depression is one of the most common diseases of perinatal distress, but the current research of high-quality prevention and treatment of postpartum depression is still very lack. The study suggests that the risk of postpartum depression in cesarean delivery is significantly higher than that in vaginal delivery. Therefore, postpartum depression in cesarean delivery may require more attention and treatment.Tramadol is a non-opioid central analgesic that relieves common to severe pain, and tramadol has an inhibitory effect on norepinephrine and serotonin systems and has the potential to reduce depression and anxiety. Therefore, for the analgesic demand and antidepressant demand for maternal who undergoing cesarean section, tramadol may be an optimized and effective analgesic for the prevention and treatment of postpartum depression.

Timeline

Start
2017-10-09
Primary completion
2019-06-13
Completion
2019-08-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified 0.04 mg/ml Intravenous
Comparator Ropivacaine Other / unclassified 1.5 mg/ml Other
Comparator Tramadol Other / unclassified 4 mg/ml Intravenous

Indications

No indication recorded.